MYMuhammed Enes Yilmaz

Muhammed Enes Yilmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammed Enes Yilmaz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of Antiproliferative Effects of Heracleum persicum Extracts on Glioblastoma Multiforme Cell Line

    by Kemal Alp Nalcı, Leyla Güven, Ravza Manto, Nefise Şentürk, Gökhan Dervişoğlu, Fethi Ahmet Ozdemir, Umut Furkan Bayram, Muhammed Enes Yılmaz, Seda Nur Yöndeş, Adnan Çetin

    Heracleum persicum (H. percium) is a plant known for its anti-inflammatory, analgesic, anticonvulsant, and antioxidant properties. In this study, the antiproliferative effects of the ethanolic leaf and root extracts of the plant on the human Glioblastoma Multiforme U-87MG cell line were evaluated. The leaf and root extracts were applied at concentrations of 10⁻¹, 10⁻², 10⁻³, 10⁻⁴, 10⁻⁵, and 10⁻⁶ mg/mL for 24 and 72 hours, and cell viability was determined using the MTT assay. The results showed that at a concentration of 10⁻¹ mg/mL for 24 hours, the leaf and root extracts caused cell death at rates of 76% and 81%, respectively. In the 72-hour application, the leaf extract at a concentration of 10⁻¹ mg/mL led to 83% cell death, while the root extract at the same concentration caused 92% cell death. These findings demonstrate that H. persicum extracts exhibit antiproliferative effects on the U-87MG cell line and suggest their potential as therapeutic agents.


  • Comprehensive phytochemical analysis of Salvia hispanica L. callus extracts using LC–MS/MS

    by Şenol Çelik, Gökhan Dervişoğlu, Ebubekir İzOl, Łukasz Sęczyk, Fethi Ahmet Özdemir, Muhammed Enes Yilmaz, Mustafa Abdullah Yilmaz, İlHami Gülçin, Khalid Mashay Al‐Anazi, Mohammad Abul Farah, et al.

    In this research, the study utilized the root, leaf, and petiole parts of in vitro grown Salvia hispanica plants as explants. Following UV‐C treatment applied to developing callus, methanol extracts were obtained and analyzed using liquid chromatography–mass spectrometry (LC/MS) to investigate their anticancer properties. First, the seeds of S. hispanica were soaked in commercial bleach for 6 min to ensure surface sterilization. The most effective antimicrobial activity on Gram‐negative bacteria, with a zone diameter (11 ± 0.82 mm), was noticed in callus extracts obtained from the petiole explant in the second protocol against Klebsiella pneumoniae EMCS bacteria. Anticancer activities on SH‐SY5Y human neuroblastoma cells were investigated by using 1000, 500, 250, 125, 62.5, 31.25, 15.62, and 78.12 μg/mL doses of the extracts, and the most effective cytotoxic activity was determined at the 1000 μg/mL dose of the extracts obtained from both protocols. The extracts were determined to inhibit hCAI, hCAII, AChE, and BChE enzymes. The content of 53 different phytochemical components of the extracts was analyzed by liquid chromatography with tandem mass spectrometry (LC–MS/MS). Rosmarinic acid, quinic acid, and caffeic acid were found in the highest concentration. The comprehensive LC–MS/MS analysis of S. hispanica extracts revealed a diverse array of phytochemical compounds, highlighting its potential for therapeutic applications.